Detalhe da pesquisa
1.
Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer.
Ann Oncol
; 28(4): 769-776, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27998973
2.
Loss of AF6/afadin, a marker of poor outcome in breast cancer, induces cell migration, invasiveness and tumor growth.
Oncogene
; 30(36): 3862-74, 2011 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-21478912